Axsome pushes back generic entry for narcolepsy drug until 2040

June 3, 2026 01:37 PM EDT PharmaLaw Ax­some push­es back gener­ic en­try for nar­colep­sy drug un­til 2040 Nicole DeFeudis Senior Reporter Ax­some Ther­a­peu­tics has suc­cess­ful­ly de­layed gener­ic com­pe­ti­tion for its nar­colep­sy drug Sunosi un­til 2040. The com­pa­ny an­nounced on Wednes­day that it … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER